Ivana Puliafito

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

Laura D. Locati, Alessandro Piovesan, Cosimo Durante et al. · European Journal of Cancer · 2019 · 97 citations · Full text

Medicine, Oncology, Pharmacology +12

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Sara Pusceddu, Claudio Vernieri, Massimo Di Maïo et al. · Gastroenterology · 2018 · 89 citations · Full text

Medicine, Endocrinology, Oncology +11

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors

Sara Pusceddu, Natalie Prinzi, Salvatore Tafuto et al. · JAMA Network Open · 2022 · 59 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression

Sarah Adriana Scuderi, Giovanna Casili, Rossella Basilotta et al. · International Journal of Molecular Sciences · 2021 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group

Antongiulio Faggiano, Silvana Di Maio, Carmela Mocerino et al. · Endocrine · 2019 · 35 citations · Full text

Medicine, Endocrinology, Oncology +12